Resideo Technologies, Inc.
REZI NYSE Wholesale-Hardware Financials FY2016βFY2025
What Resideo Technologies, Inc. does
No business description yet.
- Legal name
- RESIDEO TECHNOLOGIES, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001740332-26-000005
0001740332
Revenue and margins
Resideo Technologies, Inc. had $7.5B of revenue in fiscal 2025, up 10.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$1.3B in fiscal 2025, β16.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Resideo Technologies, Inc. returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Resideo Technologies, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $775M | $326M | $636M | $692M | $661M |
| Debt incl. finance leases | $1.2B | $1.4B | $1.4B | $2.0B | $3.2B |
| Net debt / EBITDA | 0.7x | 1.6x | 1.2x | 2.0x | 3.2x |
| Debt / equity | 0.6x | 0.6x | 0.5x | 0.6x | 1.1x |
| Interest coverage | 11.6x | 11.3x | 8.4x | 6.4x | 4.5x |
| Current ratio | 1.7x | 1.6x | 1.8x | 1.8x | 1.9x |
| Quick ratio | 1.2x | 1.0x | 1.2x | 1.1x | 1.1x |
| Total assets | $5.9B | $6.4B | $6.6B | $8.2B | $8.4B |
| Total liabilities | $3.6B | $3.9B | $3.9B | $4.9B | $5.5B |
| Shareholders' equity | $2.3B | $2.5B | $2.7B | $3.3B | $2.9B |
| Net debt (β = net cash) | $468M | $1.1B | $783M | $1.3B | $2.6B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 6 / 8 | 4 / 9 | 6 / 9 | 7 / 9 | 4 / 9 | 6 / 9 | 4 / 9 | 4 / 9 |
| Accruals ratio | β | β9.6% | β1.2% | 0.3% | β3.9% | β1.3% | 2.1% | β3.5% | β4.4% | 7.3% |
| Altman Z'' | β | β | 1.56 | 1.21 | 1.80 | 2.65 | 2.62 | 2.89 | 2.60 | 2.42 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.5B | $4.5B | $4.8B | $5.0B | $5.1B | $5.8B | $6.4B | $6.2B | $6.8B | $7.5B |
| Net interest income | β | β | β | β | β$63.0M | β$47.0M | β$54.0M | β$65.0M | β | β |
| Gross profit | $1.4B | $1.3B | $1.4B | $1.3B | $1.3B | $1.6B | $1.8B | $1.7B | $1.9B | $2.2B |
| Research and development | β | β | β | $87.0M | $74.0M | $86.0M | $111M | $109M | $111M | $167M |
| Operating income | $530M | $445M | $493M | $258M | $311M | $559M | $611M | $547M | $520M | $607M |
| Interest expense | β | β | $20.0M | $69.0M | $63.0M | $48.0M | $54.0M | $65.0M | $81.0M | $135M |
| Pretax income | $310M | $166M | $104M | $71.0M | $101M | $353M | $418M | $313M | $221M | β$457M |
| Income tax | $133M | $560M | β$301M | $35.0M | $64.0M | $111M | $135M | $103M | $105M | $70.0M |
| Net income | $177M | β$394M | $405M | $36.0M | $37.0M | $242M | $283M | $210M | $116M | β$527M |
| Net income to common | β | β | β | β | β | β | $283M | $210M | $91.0M | β$562M |
| Diluted EPS | $1.44 | β$3.22 | $3.30 | $0.29 | $0.29 | $1.63 | $1.90 | $1.42 | $0.61 | β$3.77 |
| Diluted shares | 0.12B | 0.12B | 0.12B | 0.12B | 0.13B | 0.15B | 0.15B | 0.15B | 0.15B | 0.15B |
| Cash flow | ||||||||||
| Cash from operations | $151M | $37.0M | $462M | $23.0M | $244M | $315M | $152M | $440M | $444M | β$1.1B |
| Capital expenditure | $60.0M | $49.0M | $64.0M | β | $70.0M | $63.0M | $85.0M | $105M | $80.0M | $116M |
| Free cash flow | $91.0M | β$12.0M | $398M | β | $174M | $252M | $67.0M | $335M | $364M | β$1.3B |
| Depreciation and amortization | $64.0M | $67.0M | $66.0M | $80.0M | $86.0M | $88.0M | $94.0M | $98.0M | $144M | $195M |
| Stock-based compensation | $13.0M | $16.0M | $20.0M | $25.0M | $29.0M | $39.0M | $50.0M | $44.0M | $59.0M | $57.0M |
| Acquisitions | $120M | β | β | $17.0M | $35.0M | $11.0M | $665M | $16.0M | $1.3B | $0.0M |
| Share buybacks | β | β | β | β | β | $0.0M | $0.0M | $41.0M | $1.0M | $0.0M |
| Dividends and buybacks | β | β | β | β | β | $0.0M | $0.0M | $41.0M | $1.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $47.0M | $56.0M | $265M | $122M | $517M | $775M | $326M | $636M | $692M | $661M |
| Total debt | β | β | $1.2B | $1.2B | $1.2B | $1.2B | $1.4B | $1.4B | $2.0B | $3.2B |
| Current assets | β | $1.4B | $1.8B | $1.8B | $2.2B | $2.5B | $2.5B | $2.7B | $3.2B | $3.4B |
| Current liabilities | β | $1.1B | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | $1.8B | $1.8B |
| Inventory | β | $465M | $628M | $671M | $672M | $740M | $975M | $941M | $1.2B | $1.4B |
| Property and equipment, net | $261M | $265M | $300M | $316M | $318M | $287M | $366M | $390M | $410M | $447M |
| Goodwill | $2.6B | $2.6B | $2.6B | $2.6B | $2.7B | $2.7B | $2.7B | $2.7B | $3.1B | $3.1B |
| Intangible assets | β | $140M | $133M | $127M | $135M | $120M | $475M | $461M | $1.2B | $1.1B |
| Total assets | β | $4.5B | $5.0B | $5.1B | $5.6B | $5.9B | $6.4B | $6.6B | $8.2B | $8.4B |
| Total liabilities | β | $1.9B | $3.4B | $3.5B | $3.6B | $3.6B | $3.9B | $3.9B | $4.9B | $5.5B |
| Preferred stock | β | β | β | β | β | β | β | $0.0M | $482M | $482M |
| Shareholders' equity | $2.9B | $2.6B | $1.5B | $1.6B | $2.0B | $2.3B | $2.5B | $2.7B | $3.3B | $2.9B |
| Margins | ||||||||||
| Gross margin | 30.6% | 29.1% | 29.5% | 25.6% | 26.5% | 27.1% | 27.7% | 27.2% | 28.1% | 29.4% |
| Operating margin | 11.9% | 9.8% | 10.2% | 5.2% | 6.1% | 9.6% | 9.6% | 8.8% | 7.7% | 8.1% |
| EBITDA margin | 13.3% | 11.3% | 11.6% | 6.8% | 7.8% | 11.1% | 11.1% | 10.3% | 9.8% | 10.7% |
| Net margin | 4.0% | β8.7% | 8.4% | 0.7% | 0.7% | 4.1% | 4.4% | 3.4% | 1.7% | β7.1% |
| FCF margin | 2.0% | β0.3% | 8.2% | β | 3.4% | 4.3% | 1.1% | 5.4% | 5.4% | β16.8% |
| Net interest share of revenue | β | β | β | β | β1.2% | β0.8% | β0.8% | β1.0% | β | β |
| Returns | ||||||||||
| Return on capital | β | β | 20.0% | 6.3% | 7.7% | 14.1% | 11.4% | 10.4% | 7.3% | 8.7% |
| Return on capital employed | β | 13.4% | 14.2% | 7.1% | 7.6% | 12.8% | 12.6% | 10.7% | 8.1% | 9.1% |
| Return on equity | 6.2% | β14.4% | 19.6% | 2.3% | 2.1% | 11.4% | 11.8% | 8.0% | 3.8% | β16.9% |
| Return on assets | β | β8.8% | 8.6% | 0.7% | 0.7% | 4.2% | 4.6% | 3.2% | 1.6% | β6.3% |
| Return on tangible equity | 63.2% | β | β | β | β | β | β | β | β | β |
| Growth | ||||||||||
| Revenue growth | β | 1.4% | 6.8% | 3.3% | 1.7% | 15.3% | 9.0% | β2.0% | 8.3% | 10.5% |
| Net income growth | β | β322.6% | β | β91.1% | 2.8% | 554.1% | 16.9% | β25.8% | β44.8% | β554.3% |
| EPS growth | β | β323.6% | β | β91.2% | 0.0% | 462.1% | 16.6% | β25.3% | β57.0% | β718.0% |
| FCF growth | β | β113.2% | β | β | β | 44.8% | β73.4% | 400.0% | 8.7% | β444.2% |
| Share count change | β | 0.0% | 0.1% | 0.5% | 2.2% | 17.5% | 0.7% | β0.7% | 0.7% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | 1.7x | 3.1x | 1.6x | 0.7x | 1.6x | 1.2x | 2.0x | 3.2x |
| Debt / equity | β | β | 0.8x | 0.7x | 0.6x | 0.6x | 0.6x | 0.5x | 0.6x | 1.1x |
| Interest coverage | β | β | 24.7x | 3.7x | 4.9x | 11.6x | 11.3x | 8.4x | 6.4x | 4.5x |
| Current ratio | β | 1.2x | 1.2x | 1.2x | 1.4x | 1.7x | 1.6x | 1.8x | 1.8x | 1.9x |
| Quick ratio | β | 0.8x | 0.8x | 0.7x | 1.0x | 1.2x | 1.0x | 1.2x | 1.1x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.3% | 1.1% | 1.3% | β | 1.4% | 1.1% | 1.3% | 1.7% | 1.2% | 1.6% |
| Stock comp / revenue | 0.3% | 0.4% | 0.4% | 0.5% | 0.6% | 0.7% | 0.8% | 0.7% | 0.9% | 0.8% |
| Payouts / FCF | β | β | β | β | β | 0.0% | 0.0% | 12.2% | 0.3% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 6.0 | 4.0 | 6.0 | 7.0 | 4.0 | 6.0 | 4.0 | 4.0 |
| Altman Z'' | β | β | 1.6 | 1.2 | 1.8 | 2.6 | 2.6 | 2.9 | 2.6 | 2.4 |
| Accruals ratio | β | β9.6% | β1.2% | 0.3% | β3.9% | β1.3% | 2.1% | β3.5% | β4.4% | 7.3% |
Source: SEC EDGAR XBRL filings (CIK 0001740332). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.